awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38964908-0602AEB5-D937-43FE-81B6-281606799246
Q38964908-0602AEB5-D937-43FE-81B6-281606799246
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964908-0602AEB5-D937-43FE-81B6-281606799246
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.
P2860
Q38964908-0602AEB5-D937-43FE-81B6-281606799246
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38964908-0602AEB5-D937-43FE-81B6-281606799246
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0c8fbf96dc6239a9e60d5840dff2cd20ae152ea
P2860
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.